Skip to content
Screener

Bio-Techne TECH Corporate — Restructuring Charges

Other segment segments

Protein Sciences
$2.12M+1,544%
Diagnostics And Spatial Biology
$27K—

Similar metrics at other companies

Bruker logo
BRKRCorporate — Restructuring Charges
$1M-16.7%
Fortune Brands Innovations logo
FBINCorporate — Restructuring Charges
$4M+14.3%
Gentherm logo
THRMCorporate — Restructuring Charges
$23K-17.9%
Olin logo
OLNCorporate/ other — Restructuring Charges
$9.1M+127%
Huron Consulting Group logo
HURNCorporate Segment — Restructuring Charges
$1.5M-21.1%
Enerpac Tool Group logo
EPACGeneral Corporate — Restructuring Charges
$0-100%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemEmployee / severanceAsset-related / and otherRecovery of / assets held-for-saleTotal
Protein Sciences$$556$1,565—2,121
Diagnostics and Spatial Biology27——27
Corporate454234—688
Total$$1,037$1,799—2,836

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's corporate — restructuring charges?
Bio-Techne (TECH) reported corporate — restructuring charges of $688K in Q1 2026.
How has Bio-Techne's corporate — restructuring charges changed year-over-year?
Bio-Techne's corporate — restructuring charges increased by 136.4% year-over-year, from $291K to $688K.
What does corporate — restructuring charges mean?
This metric represents the non-recurring expenses recognized by the corporate segment related to organizational realignment, workforce reductions, or facility consolidations. These charges are typically incurred to improve long-term operational efficiency and cost structure. Investors monitor these to assess the impact of strategic shifts on corporate overhead.

Ask your AI about Bio-Techne's corporate — restructuring charges.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude